Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
15.68 USD | -0.35% | -8.02% | -13.09% |
05-09 | UBS Adjusts Price Target on REGENXBIO to $39 From $43, Maintains Buy Rating | MT |
05-08 | Transcript : REGENXBIO Inc., Q1 2024 Earnings Call, May 08, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.09% | 775M | |
+4.35% | 111B | |
+11.11% | 105B | |
-12.16% | 22.34B | |
-3.90% | 21.93B | |
-5.99% | 18.59B | |
-36.52% | 18.12B | |
-9.94% | 16.96B | |
+3.40% | 13.7B | |
+36.45% | 12.45B |
- Stock Market
- Equities
- RGNX Stock
- News REGENXBIO Inc.
- Morgan Stanley Raises REGENXBIO's Price Target to $52 From $46, Maintains Overweight Rating